TY  - GEN
AU  - Sinnberg,Tobias
AU  - Makino,Elena
AU  - Krueger,Marcel A
AU  - Velic,Ana
AU  - Macek,Boris
AU  - Rothbauer,Ulrich
AU  - Groll,Nicola
AU  - Pötz,Oliver
AU  - Czemmel,Stefan
AU  - Niessner,Heike
AU  - Meier,Friedegund
AU  - Ikenberg,Kristian
AU  - Garbe,Claus
AU  - Schittek,Birgit
TI  - A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib
SN  - 2352-3964
PY  - 2017///0214
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Disease Models, Animal
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Indoles
KW  - Melanoma
KW  - drug therapy
KW  - Mice
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - antagonists & inhibitors
KW  - Resin Cements
KW  - STAT3 Transcription Factor
KW  - metabolism
KW  - Sulfonamides
KW  - Vemurafenib
KW  - Wnt Signaling Pathway
KW  - Xenograft Model Antitumor Assays
KW  - beta Catenin
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ebiom.2016.04.037
ER  -